Company Information
 
 
 Stock Code Search Company Search
 
Company ProfileCompany StructureProfit & LossBalance Sheet
翰思艾泰生物醫藥科技(武漢)股份有限公司 Code:  03378
HANX BIOPHARMACEUTICALS (WUHAN) CO., LTD. Website: http://www.hanxbio.com
Income Statement
  2024/12
RMB(K$)
Change 2023/12
RMB(K$)
/
RMB(K$)
Turnover0--0--
Operating Profit / (Loss)(122,820)--(93,423)--
Exceptional Items--------
Profit / (Loss) of Associated Co. & Jointly Controlled Entity0--0--
Profit / (Loss) before Taxation(122,820)--(93,423)--
Taxation5,898-28.622%8,263--
Minority Interests1,092-88.005%9,104--
Profit / (Loss) Attributable to Shareholders(115,830)--(76,056)--
 
Net Interest Income / (Expense)(6,455)--1,845--
Depreciation & Amortization5,479426.321%1,041--
Directors Remuneration14,8491,023.222%1,322--
 
EPS / (LPS) (cts)--------
DPS (cts)--------
 
Dividend Payout Ratio (%)--------
NBV Per Share ($)--------
Financial Ratio
  2024/12
RMB(K$)
Change 2023/12
RMB(K$)
/
RMB(K$)
Operating Margin (%)--------
Interest Coverage Ratio (x)--------
ROAA (%)(21.298)%------
ROAE (%)(53.333)%------
 
Copyright ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.